CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-01-08 | Aryeh Jason Director | Sale | −46,157 | $5.29 | $244K | 687,420 |
| 2010-01-07 | Aryeh Jason Director | Sale | −3,443 | $5.29 | $18K | 733,577 |
| 2010-01-06 | Aryeh Jason Director | Sale | −42,365 | $5.24 | $222K | 737,020 |
| 2009-12-22 | Aryeh Jason Director | Sale | −8,035 | $5.24 | $42K | 779,385 |
| 2009-12-16 | Aryeh Jason Director | Sale | −4,045 | $5.24 | $21K | 787,420 |
| 2009-11-30 | FAHIM RAAFAT E F President, CEO and CFO | Other acquisition | +5,404.28 | $2.41 | $13K | 283,818.94 |
| 2009-11-30 | Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops | Other acquisition | +5,404.28 | $2.41 | $13K | 39,523.1 |
| 2009-11-23 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −602 | $5.00 | $3K | 82,500 |
| 2009-11-23 | DAVIS PETER B Director | Purchase | +800 | $4.98 | $4K | 8,614 |
| 2009-11-23 | DAVIS PETER B Director | Purchase | +2,200 | $4.98 | $11K | 10,814 |
| 2009-11-20 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −1,000 | $4.92 | $5K | 97,740 |
| 2009-11-20 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −2,000 | $4.91 | $10K | 95,740 |
| 2009-11-20 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −7,136 | $4.90 | $35K | 88,604 |
| 2009-11-20 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −5,502 | $4.89 | $27K | 83,102 |
| 2009-11-19 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −2,500 | $4.90 | $12K | 98,740 |
| 2009-11-17 | Aryeh Jason Director | Sale | −200 | $5.25 | $1K | 977,174 |
| 2009-11-17 | Aryeh Jason Director | Sale | −58,709 | $5.24 | $308K | 918,465 |
| 2009-11-17 | Aryeh Jason Director | Sale | −500 | $5.22 | $3K | 917,965 |
| 2009-11-17 | Aryeh Jason Director | Sale | −500 | $5.12 | $3K | 917,465 |
| 2009-11-17 | Aryeh Jason Director | Sale | −5,000 | $5.10 | $26K | 912,465 |
Page 32 of 42 · 830 trades